Flagship startup loses CEO to Ipsen; Ionis to shed nearly six decades of board experiencenews2026-03-13T11:00:13+00:00March 13th, 2026|Endpoints News|
Lilly plucks Flagship, bluebird vet for regenerative medicine unit; Novo’s new China presidentnews2026-03-06T12:00:41+00:00March 6th, 2026|Endpoints News|
Doug Ingram’s uneven legacy at Sarepta; Merck splits human health business, brings in Sanofi execnews2026-02-27T12:00:10+00:00February 27th, 2026|Endpoints News|
Sanofi appoints specialty care head; Biogen chair to retire in Junenews2026-02-20T12:00:30+00:00February 20th, 2026|Endpoints News|
Paul Hudson couldn’t quite get Sanofi over the hump; PROTAC developer Arvinas appoints CEOnews2026-02-13T12:00:16+00:00February 13th, 2026|Endpoints News|
Geoff McDonough’s big plans for NodThera’s NLRP3; Enhertu leader steps down at Daiichinews2026-02-06T12:00:41+00:00February 6th, 2026|Endpoints News|
Janux hires CMO after T cell engager deal with Bristol Myers; A batch of appointments at Lexeonews2026-01-30T12:00:04+00:00January 30th, 2026|Endpoints News|
Former FDA deputies land at Lilly, AbbVie; Italy’s Angelini has a new CEOnews2026-01-23T12:00:32+00:00January 23rd, 2026|Endpoints News|
Novo Nordisk, BioMarin make AI moves; Bristol Myers welcomes neurology exec from Eisainews2026-01-16T12:00:18+00:00January 16th, 2026|Endpoints News|
Viking gets commercial chief while other obesity biotechs sell; Novo’s Uli Stilz steps downnews2026-01-09T12:00:54+00:00January 9th, 2026|Endpoints News|
